These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 27160755)

  • 21. Statins for the prevention of first or recurrent stroke.
    Athyros VG; Kakafika AI; Tziomalos K; Papageorgiou AA; Karagiannis A
    Curr Vasc Pharmacol; 2008 Apr; 6(2):124-33. PubMed ID: 18393914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholesterol-independent effects of statins and new therapeutic targets: ischemic stroke and dementia.
    Miida T; Hirayama S; Nakamura Y
    J Atheroscler Thromb; 2004; 11(5):253-64. PubMed ID: 15557707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The acute (cerebro)vascular effects of statins.
    Prinz V; Endres M
    Anesth Analg; 2009 Aug; 109(2):572-84. PubMed ID: 19608834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Bayesian network meta-analysis of PCSK9 inhibitors, statins and ezetimibe with or without statins for cardiovascular outcomes.
    Khan SU; Talluri S; Riaz H; Rahman H; Nasir F; Bin Riaz I; Sattur S; Ahmed H; Kaluski E; Krasuski R
    Eur J Prev Cardiol; 2018 May; 25(8):844-853. PubMed ID: 29569492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
    Hennekens CH; Schneider WR
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for prevention of stroke.
    Warshafsky S; Packard D; Marks SJ; Sachdeva N; Terashita DM; Kaufman G; Sang K; Deluca AJ; Peterson SJ; Frishman WH
    J Gen Intern Med; 1999 Dec; 14(12):763-74. PubMed ID: 10632823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statin therapy for stroke prevention.
    Nassief A; Marsh JD
    Stroke; 2008 Mar; 39(3):1042-8. PubMed ID: 18258828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New insights into the pleiotropic effects of statins for stroke prevention.
    Pezzini A; Del Zotto E; Volonghi I; Giossi A; Costa P; Padovani A
    Mini Rev Med Chem; 2009 Jun; 9(7):794-804. PubMed ID: 19519504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.
    Vrecer M; Turk S; Drinovec J; Mrhar A
    Int J Clin Pharmacol Ther; 2003 Dec; 41(12):567-77. PubMed ID: 14692706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The need for increased utilization of statins after occlusive stroke.
    Hebert PR; Evans D; Schneider WR; Rodriquez-Paz E; Hennekens CH
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):364-7. PubMed ID: 21193682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statins and stroke: prevention and beyond.
    Prinz V; Endres M
    Curr Opin Neurol; 2011 Feb; 24(1):75-80. PubMed ID: 21150596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical trials: Evidence and unanswered questions--hyperlipidaemia.
    Deanfield JE
    Cerebrovasc Dis; 2003; 16 Suppl 3():25-32. PubMed ID: 12740553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Secondary prevention of recurrent stroke by lowering cholesterol levels and blood pressure].
    Stalenhoef AF
    Ned Tijdschr Geneeskd; 2006 Sep; 150(39):2127-30. PubMed ID: 17059084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Statins and cerebrovascular disease: new perspectives in stroke prevention].
    Castilla-Guerra L; Fernández-Moreno MC; López-Chozas JM; Jiménez-Hernández MD
    Rev Neurol; 2007 Jan 16-31; 44(2):95-100. PubMed ID: 17236149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One statin, two statins, three statins, more: similarities and differences of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Turkoski BB
    Orthop Nurs; 2011; 30(1):62-5; quiz 66-7. PubMed ID: 21278557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should statins be given routinely before carotid endarterectomy?
    Perler BA
    Perspect Vasc Surg Endovasc Ther; 2007 Sep; 19(3):240-5. PubMed ID: 17911547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same?
    Evans M; Rees A
    Drug Saf; 2002; 25(9):649-63. PubMed ID: 12137559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beyond the laboratory: clinical implications for statin pleiotropy.
    Halcox JP; Deanfield JE
    Circulation; 2004 Jun; 109(21 Suppl 1):II42-8. PubMed ID: 15173062
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.